Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 1 |
2008 | 1 |
2009 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Inhibitors of HER2/neu (erbB-2) signal transduction.
Semin Oncol. 2001 Dec;28(6 Suppl 18):30-5.
Semin Oncol. 2001.
PMID: 11774203
Review.
Overcoming resistance to tyrosine kinase inhibitors: lessons learned from cancer cells treated with EGFR antagonists.
Rexer BN, Engelman JA, Arteaga CL.
Rexer BN, et al.
Cell Cycle. 2009 Jan 1;8(1):18-22. doi: 10.4161/cc.8.1.7324. Epub 2009 Jan 30.
Cell Cycle. 2009.
PMID: 19106609
Free PMC article.
Review.
Item in Clipboard
A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer.
Arteaga CL, O'Neill A, Moulder SL, Pins M, Sparano JA, Sledge GW, Davidson NE.
Arteaga CL, et al.
Clin Cancer Res. 2008 Oct 1;14(19):6277-83. doi: 10.1158/1078-0432.CCR-08-0482.
Clin Cancer Res. 2008.
PMID: 18829509
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite